Mark A Beilke

Summary

Affiliation: Tulane University
Country: USA

Publications

  1. ncbi Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2
    Mark A Beilke
    Department of Medicine, Tulane University Health Sciences Center, New Orleans, LA 70112, USA
    Clin Infect Dis 39:256-63. 2004
  2. ncbi Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients
    Mark A Beilke
    Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USA
    Clin Infect Dis 41:e57-63. 2005
  3. ncbi Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection
    Mark A Beilke
    Tulane University Health Sciences Center School of Medicine, New Orleans, Louisiana, USA
    Clin Infect Dis 44:1229-34. 2007
  4. ncbi Human T cell leukemia virus type 1 up-regulation after simian immunodeficiency virus-1 coinfection in the nonhuman primate
    Vicki L Traina-Dorge
    Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433, USA
    J Infect Dis 195:562-71. 2007
  5. ncbi Upregulation of HTLV-1 and HTLV-2 expression by HIV-1 in vitro
    Upal Roy
    Department of Pharmacology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA
    J Med Virol 80:494-500. 2008
  6. ncbi Acute hypersensitivity reaction to enfuvurtide upon re-challenge
    Mark A Beilke
    Scand J Infect Dis 36:778. 2004

Collaborators

Detail Information

Publications6

  1. ncbi Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2
    Mark A Beilke
    Department of Medicine, Tulane University Health Sciences Center, New Orleans, LA 70112, USA
    Clin Infect Dis 39:256-63. 2004
    ..In conclusion, HIV-HTLV-I/II coinfection may result in improved survival and delayed progression to AIDS, but this happens at the expense of an increased frequency of other of clinical complications...
  2. ncbi Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients
    Mark A Beilke
    Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USA
    Clin Infect Dis 41:e57-63. 2005
    ..Among HTLV-1- or HTLV-2-monoinfected individuals, the estimated lifetime risk for development of TSP/HAM is <2%. However, it has been suggested that HIV/HTLV coinfection may increase the risk for development of TSP/HAM...
  3. ncbi Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection
    Mark A Beilke
    Tulane University Health Sciences Center School of Medicine, New Orleans, Louisiana, USA
    Clin Infect Dis 44:1229-34. 2007
    ..The long-term effects of coinfection are unknown, and little information exists regarding how levels of HTLV-1/2 viral burden are affected by antiretroviral medications...
  4. ncbi Human T cell leukemia virus type 1 up-regulation after simian immunodeficiency virus-1 coinfection in the nonhuman primate
    Vicki L Traina-Dorge
    Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433, USA
    J Infect Dis 195:562-71. 2007
    ..We conclude that SIV may have the potential to up-regulate HTLV-1 and disease expression...
  5. ncbi Upregulation of HTLV-1 and HTLV-2 expression by HIV-1 in vitro
    Upal Roy
    Department of Pharmacology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA
    J Med Virol 80:494-500. 2008
    ..It is concluded that HIV-1 augments HTLV-1/2 infectivity in vitro. The findings also suggest a role for the HIV-1 Tat protein and PMA-inducible cellular factors, in HIV-1 induced HTLV-1/2 antigen expression...
  6. ncbi Acute hypersensitivity reaction to enfuvurtide upon re-challenge
    Mark A Beilke
    Scand J Infect Dis 36:778. 2004